Evaluation and Implementation of an mHealth Intervention Called Mami-educ to Fight Against Gestational Obesity

October 31, 2022 updated by: Delia Indira Chiarello, Universidad San Sebastián

Evaluation and Implementation of an mHealth Intervention to Prevent Gestational Obesity in the Metropolitan Region and the Aconcagua Valley.

The World Federation of Obesity warns that the main health problem of the next decade will be childhood obesity. Furthermore, obesity and its consequences have been reported to originate in intrauterine life. Gestational obesity produces profound effects on fetal genome programming, thereby inducing changes in prenatal metabolism that extend to the postnatal period, which is also associated with increased susceptibility to developing cardiovascular and metabolic diseases in adulthood.

Excessive maternal weight gain early in pregnancy has been repeatedly associated with increased adiposity in childhood and adolescence of its offspring. Obesity is a complex phenomenon influenced by social determinants of health, which include demographic, socioeconomic, behavioral, environmental, and genetic factors. At the primary prevention level, nutrition constitutes a modifiable risk factor during pregnancy. Therefore establishing healthy nutritional behaviors during the first trimester of pregnancy is key to the primary prevention of the intergenerational transmission of obesity.

New ways of approaching the target population are required to maintain nutritional recommendations as a priority in the daily decision-making (top of mind) of pregnant women. For many women, this period is a powerful motivator for self-care.

Interventions based on behavioral theories provide a better understanding of the underlying mechanisms that determine health-related behavior change and have the potential to be more effective in promoting adherence to weight gain control. Social Cognitive Theory (TCS) is an integrated model of behavior change commonly applied in mobile health interventions that address diet, physical activity or weight loss.

Mobile health programs (mHealth) are potentially more effective than face-to-face interventions, especially during a public health emergency like the COVID-19 outbreak. This proposal intends to "deliver" messages with evidence-based information directly to pregnant women, in order to influence their nutritional behavior to avoid excessive gestational weight gain.

The hypothesis of this proposal is that the mHealth intervention called "mami-educ", which consists of sending messages with nutrition counseling during pregnancy through the Telegram platform, is effective in reducing excessive gestational weight gain in pregnant women attending Family Health Care Centers in an urban and predominantly rural area.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

511

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Providencia
      • Santiago, Providencia, Chile
        • Recruiting
        • Delia I Chiarello
        • Contact:
        • Principal Investigator:
          • Delia I Chiarello, Ph.D.
        • Sub-Investigator:
          • Jessica Moya, Msc
    • Valparaíso
      • San Felipe, Valparaíso, Chile

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Pregnant women who receive care in the 6 CESFAMs of El Bosque and Aconcagua Valley over 18 years of age; pregnant women with gestational age ≤ 12 weeks of gestation (first trimester)
  • Pregnant women with a single pregnancy
  • Healthy pregnant women
  • Chilean or immigrant women who speak Spanish
  • The participants must have a mobile device that allows the use of the Telegram application
  • Pregnant women who agree to be randomized
  • Pregnant women who have voluntarily signed the informed consent to participate in this study

Exclusion Criteria:

  • A multiple pregnancy
  • Conditions that require a special diet
  • Participants with psychiatric illness or other pre-pregnancy pathology
  • History of recurrent abortions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual care group
Pregnant women enrolled in the prenatal control program who receive routine medical care.
Experimental: mami-educ group
Pregnant women enrolled in the prenatal care program who receive routine medical care and nutritional messages mom-educ.
The intervention corresponds to sending 3 messages a week through Telegram, with nutritional information, for 12 consecutive weeks (a different nutritional topic each week). The messages address the three domains of learning, cognitive, affective, and psychomotor for each topic.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gestational weight gain
Time Frame: Nine months
Maternal weight gain measure in kilograms by month
Nine months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal outcome
Time Frame: Nine months
Medical diagnosis of of either preeclampsia, gestational diabetes or gestational hypertension
Nine months
Perinatal outcome
Time Frame: At birth
Labor delivery week
At birth
Apgar score
Time Frame: At birth
Apgar score report
At birth
Newborn birth weight
Time Frame: At birth
Newborn birth weight measure in grams
At birth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Delia I Chiarello, Ph.D, Universidad San Sebastian

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 3, 2022

Primary Completion (Anticipated)

July 1, 2023

Study Completion (Anticipated)

December 18, 2023

Study Registration Dates

First Submitted

October 15, 2021

First Submitted That Met QC Criteria

October 28, 2021

First Posted (Actual)

November 9, 2021

Study Record Updates

Last Update Posted (Actual)

November 3, 2022

Last Update Submitted That Met QC Criteria

October 31, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gestational Weight Gain

Clinical Trials on mami-educ

3
Subscribe